|
| Press Releases |
|
 |
|
| Wednesday, February 26, 2014 |
|
|
Cytokinetics Announces Closing of its Public Offering of Common Stock and Exercise of Option to Purchase Additional Shares |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today the closing of its previously announced underwritten public offering of 4,375,000 shares of its common stock, as well as 656,250 additional shares of its common stock pursuant to the full exercise of the underwriters' option to purchase additional shares. more info >> |
|
| Friday, February 21, 2014 |
|
|
Cytokinetics Announces pricing of $35.0 Million Public Offering of Common Stock |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today the pricing of its previously announced underwritten public offering of 4,375,000 shares of its common stock at a price to the public of $8.00 per share. more info >> |
|
| Thursday, February 20, 2014 |
|
|
Cytokinetics Announces Proposed Public Offering of Common Stock |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. more info >> |
|
| Friday, February 7, 2014 |
|
|
Cytokinetics, Incorporated Reports Fourth Quarter 2013 Financial Results |
| Cytokinetics, Incorporated (Nasdaq: CYTK) reported total revenues of $24.3 million for the fourth quarter of 2013, compared to $2.2 million during the same period in 2012. Net income for the fourth quarter was $6.5 million, or $0.22 per basic share and $0.21 per diluted share. more info >> |
|
| Wednesday, February 5, 2014 |
|
|
Cytokinetics to Present at Upcoming Healthcare Conferences |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that members of its management team are scheduled to participate at the following healthcare conferences. more info >> |
|
| Friday, January 24, 2014 |
|
|
Cytokinetics to Announce Fourth Quarter Results on February 6, 2014 |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that it is scheduled to report fourth quarter results on Thursday, February 6, 2014 at 4:00 PM Eastern Time. more info >> |
|
| Monday, January 13, 2014 |
|
|
Cytokinetics Provides Updates Regarding Clinical Development Program for Omecamtiv Mecarbil |
| Cytokinetics, Incorporated (Nasdaq: CYTK) provided updates today regarding COSMIC-HF (Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure) and other progress in the development of omecamtiv mecarbil. more info >> |
|
| Tuesday, December 10, 2013 |
|
|
Cytokinetics Announces Results from First-Time-In-Humans Clinical Trial of CK-2127107 at Conference of the Society on Sarcopenia, Cachexia and Wasting Disorders |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that the results from a first-time-in-humans clinical trial of CK-2127107 in healthy male volunteers were presented during a Late Breaking Clinical Trials session at the 7th International Conference of the Society on Sarcopenia, Cachexia and Wasting Disorders in Kobe, Japan. more info >> |
|
| Monday, December 9, 2013 |
|
|
Cytokinetics Announces Presentation Providing Update on BENEFIT-ALS at International Symposium on ALS/MND |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that a platform presentation of data from BENEFIT-ALS (Blinded Evaluation of Neuromuscular Effects and Functional Improvement with Tirasemtiv in ALS) was given at the 24th International Symposium on ALS/MND on December 7, 2013 in Milan, Italy. more info >> |
|
| Wednesday, December 4, 2013 |
|
|
Cytokinetics to Present Data Related to Skeletal Muscle Activators at Conference of Society on Sarcopenia, Cachexia and Wasting Disorders |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that two presentations, relating to its fast skeletal muscle troponin activators, are scheduled to be presented at the 7th International Conference of the Society on Sarcopenia, Cachexia and Wasting Disorders from December 9-11, 2013 in Kobe, Japan. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
沙烏地電力公司2025年第二季淨利成長22%
Aug 11, 2025 11:00 HKT/SGT
|
|
|
Shoucheng-Backed Data Center REITs Surge on Market Debut
Aug 11, 2025 09:00 HKT/SGT
|
|
|
首批數據中心REITs上市首日雙雙漲停 首程控股再顯產業資本實力
Aug 11, 2025 09:00 HKT/SGT
|
|
|
首批数据中心REITs上市首日双双涨停 首程控股再显产业资本实力
Aug 11, 2025 09:00 HKT/SGT
|
|
|
Natural Beauty 2025 Interim Profit Surges by 136% to HK$11 Million
Aug 11, 2025 08:15 HKT/SGT
|
|
|
Intellifusion Submits an Application to List on the Hong Kong Stock Exchange: A National Breakthrough in AI Inference Chips
Aug 11, 2025 08:07 HKT/SGT
|
|
|
Everest Medicines Announces Full Approval of NEFECON(R) in Taiwan
Aug 11, 2025 07:37 HKT/SGT
|
|
|
Saudi Electricity Company Reports 22% Net Profit Growth in Q2 2025
Aug 11, 2025 06:00 HKT/SGT
|
|
|
Qube Celebrates 20 Years of Business Events Impact with Industry Recognition and Vision for the Future
Aug 10, 2025 23:20 HKT/SGT
|
|
|
Intervision'25 International Music Contest to Take Place: Michael Jackson's Descendant Expected to Participate
Aug 10, 2025 22:00: JST
|
|
|
Intervision'25 International Music Contest to Take Place: Michael Jackson's Descendant Expected to Participate
Aug 10, 2025 21:00 HKT/SGT
|
|
|
親子暑假激FUN推介！新一代AI保險銷售平台HoldCover呈獻
Aug 8, 2025 21:01 HKT/SGT
|
|
|
亲子暑假激FUN推介！新一代AI保险销售平台HoldCover呈献
Aug 8, 2025 18:27 HKT/SGT
|
|
|
雲頂新耀耐賦康(R)擴產獲批 亞洲全域完全批准雙突破 加速邁向50億銷售峰值
Aug 8, 2025 18:09 HKT/SGT
|
|
|
云顶新耀耐赋康(R)扩产获批 亚洲全域完全批准双突破 加速迈向50亿销售峰值
Aug 8, 2025 18:09 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
